Indication

Long-term enzyme replacement therapy (ERT) in adult patients with confirmed diagnosis of Fabry disease (FD) (deficiency of alpha galactosidase).

Medicine details

Medicine name:
pegunigalsidase alfa (Elfabrio)
SMC ID:
SMC2665
Pharmaceutical company
Chiesi Limited
BNF chapter
Nutrition and blood
Submission type
Resubmission
Publication due date:
08 July 2024
Patient group submission deadline:
07 May 2024